Celldex Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7.6M | 181k | 41.95 |
| 2023-12-31 | $2.5M | 62k | 39.70 |
| 2023-09-30 | $1.9M | 69k | 27.57 |
| 2023-03-31 | $4.2M | 118k | 35.98 |
| 2022-12-31 | $3.3M | 74k | 44.57 |
| 2022-09-30 | $5.7M | 199k | 28.57 |
| 2021-12-31 | $12M | 299k | 38.64 |
| 2021-03-31 | $3.6M | 173k | 20.60 |
| 2020-12-31 | $624k | 36k | 17.53 |
| 2019-09-30 | $12k | 5.7k | 2.13 |
| 2019-06-30 | $34k | 6.7k | 5.00 |
| 2019-03-31 | $0 | 5.0k | 0.00 |